Pancreatic adenocarcinoma (PC) is the third most common cancer associated with BRCA mutations. Most notice has been given to BRCA2, while the association between BRCA1 and PC is less widely reported. Recently, PALB2 has been implicated in both PC and breast cancer (BC) susceptibility. We selected 29 Italian PC patients from a case-control study of PC according to their personal and family history of both PC and breast/ovarian cancer (BC/OC) and tested them for presence of germline mutations in BRCA1, BRCA2 and PALB2. We identified no germline mutations or deletions in PALB2, but detected 7 BRCA mutations (4 in BRCA1 and 3 in BRCA2). These findings suggest that PALB2 does not play a major role in PC susceptibility in our population. As we found an almost equal frequency of germline mutations in BRCA1 and BRCA2, germline alterations in either of these genes may explain a subset of Italian families presenting both PC and BC/OC. Moreover, as we began the observation of these families from probands who are affected by PC, we provide here a direct assessment of the role of PALB2 and BRCA mutations in PC susceptibility. © 2011 Springer Science+Business Media B.V.

Ghiorzo, P., Pensotti, V., Fornarini, G., Sciallero, S., Battistuzzi, L., Belli, F., et al. (2012). Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy. FAMILIAL CANCER, 11(1), 41-47 [10.1007/s10689-011-9483-5].

Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy

BONELLI, Luigi Salvatore;PALMIERI, GIOVANNI;Russo, A.;
2012

Abstract

Pancreatic adenocarcinoma (PC) is the third most common cancer associated with BRCA mutations. Most notice has been given to BRCA2, while the association between BRCA1 and PC is less widely reported. Recently, PALB2 has been implicated in both PC and breast cancer (BC) susceptibility. We selected 29 Italian PC patients from a case-control study of PC according to their personal and family history of both PC and breast/ovarian cancer (BC/OC) and tested them for presence of germline mutations in BRCA1, BRCA2 and PALB2. We identified no germline mutations or deletions in PALB2, but detected 7 BRCA mutations (4 in BRCA1 and 3 in BRCA2). These findings suggest that PALB2 does not play a major role in PC susceptibility in our population. As we found an almost equal frequency of germline mutations in BRCA1 and BRCA2, germline alterations in either of these genes may explain a subset of Italian families presenting both PC and BC/OC. Moreover, as we began the observation of these families from probands who are affected by PC, we provide here a direct assessment of the role of PALB2 and BRCA mutations in PC susceptibility. © 2011 Springer Science+Business Media B.V.
Settore MED/06 - Oncologia Medica
Ghiorzo, P., Pensotti, V., Fornarini, G., Sciallero, S., Battistuzzi, L., Belli, F., et al. (2012). Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy. FAMILIAL CANCER, 11(1), 41-47 [10.1007/s10689-011-9483-5].
File in questo prodotto:
File Dimensione Formato  
Contribution of germline mutations in the BRCA and PALB2.pdf

Solo gestori archvio

Dimensione 254.12 kB
Formato Adobe PDF
254.12 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10447/291851
Citazioni
  • ???jsp.display-item.citation.pmc??? 16
  • Scopus 27
  • ???jsp.display-item.citation.isi??? 26
social impact